Roche

Roche is a healthcare company that prioritizes research to create and offer innovative diagnostic and therapeutic solutions. Their products and services aim to greatly improve outcomes for both patients and healthcare providers. They focus on everything from early disease detection and prevention to diagnosis, treatment, and ongoing monitoring. Their mission is to address the current needs of patients and anticipate what they will require in the future.

International

English

Corporate/Government Newsroom

Outlet metrics

Domain Authority

Ranking

Global

#40505

United States

#35072

Health/Biotechnology and Pharmaceuticals

#25

Traffic sources

Monthly visitors

Articles

FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness

2 months ago | roche.com

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)With as few as two treatments per year, Susvimo...
Roche’s Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson’s disease

Dec 19, 2024 | roche.com

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpointsPrasinezumab continues to be well tolerated and no new safety signals were...
Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness

Dec 12, 2024 | roche.com

Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vialsVabysmo has demonstrated rapid and robust...
Roche | Bridging the Gap: Accessing Eye Care in Rural Areas

Nov 21, 2024 | roche.com

Roche aims to prioritise rural communities' needs. Innovative solutions and initiatives like the Eye Van Canada bring essential eye care to remote areas and transform access for conditions like nAMD and DME.
Roche | Accessibility statement

Oct 7, 2024 | roche.com

At Roche, we are committed to ensuring that our websites and digital resources are accessible to all users.
Roche | Survey highlights the global challenges of HPV and cervical cancer

Oct 7, 2024 | roche.com

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public
Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses

Sep 24, 2024 | roche.com

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers...
Roche | Stories

Sep 23, 2024 | roche.com

Patients and science are at the heart of everything we do. It is through stories of hope, innovation, collaboration and medical breakthroughs that we truly measure the reach and impact of our work.
FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

Jul 4, 2024 | roche.com

Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindnessDesigned to simplify administration, Vabysmo PFS...
Breaking the link between chronic liver disease and cancer

Oct 2, 2022 | roche.com | Philip Anderson